Get Premium to unlock powerful stock data

Avoro Capital Advisors LLC Buys Acceleron Pharma Inc, Apellis Pharmaceuticals Inc, Aadi Bioscience Inc, Sells , Relmada Therapeutics Inc, Syndax Pharmaceuticals Inc

Author's Avatar
insider
Nov 15, 2021
Article's Main Image
Investment company Avoro Capital Advisors LLC (Current Portfolio) buys Acceleron Pharma Inc, Apellis Pharmaceuticals Inc, Aadi Bioscience Inc, Amicus Therapeutics Inc, PMV Pharmaceuticals Inc, sells , Relmada Therapeutics Inc, Syndax Pharmaceuticals Inc, Olema Pharmaceuticals inc, Avadel Pharmaceuticals PLC during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Avoro Capital Advisors LLC. As of 2021Q3, Avoro Capital Advisors LLC owns 47 stocks with a total value of $6.4 billion. These are the details of the buys and sells.

For the details of Avoro Capital Advisors LLC's stock buys and sells, go to https://www.gurufocus.com/guru/avoro+capital+advisors+llc/current-portfolio/portfolio

These are the top 5 holdings of Avoro Capital Advisors LLC
  1. Horizon Therapeutics PLC (HZNP) - 9,000,000 shares, 15.49% of the total portfolio.
  2. Mirati Therapeutics Inc (MRTX) - 5,000,000 shares, 13.89% of the total portfolio.
  3. Acceleron Pharma Inc (XLRN) - 4,000,000 shares, 10.81% of the total portfolio. Shares added by 33.33%
  4. United Therapeutics Corp (UTHR) - 3,000,000 shares, 8.70% of the total portfolio.
  5. Ascendis Pharma A/S (ASND) - 1,980,000 shares, 4.96% of the total portfolio. Shares added by 4.21%
New Purchase: Aadi Bioscience Inc (AADI)

Avoro Capital Advisors LLC initiated holding in Aadi Bioscience Inc. The purchase prices were between $0 and $32.66, with an estimated average price of $27.53. The stock is now traded at around $23.520000. The impact to a portfolio due to this purchase was 0.84%. The holding were 1,829,402 shares as of 2021-09-30.

New Purchase: Kymera Therapeutics Inc (KYMR)

Avoro Capital Advisors LLC initiated holding in Kymera Therapeutics Inc. The purchase prices were between $47.8 and $66.66, with an estimated average price of $57.98. The stock is now traded at around $61.620000. The impact to a portfolio due to this purchase was 0.42%. The holding were 455,750 shares as of 2021-09-30.

New Purchase: DICE Therapeutics Inc (DICE)

Avoro Capital Advisors LLC initiated holding in DICE Therapeutics Inc. The purchase prices were between $31.92 and $37, with an estimated average price of $34.06. The stock is now traded at around $31.160000. The impact to a portfolio due to this purchase was 0.41%. The holding were 800,000 shares as of 2021-09-30.

New Purchase: Biogen Inc (BIIB)

Avoro Capital Advisors LLC initiated holding in Biogen Inc. The purchase prices were between $282.99 and $369.05, with an estimated average price of $328.16. The stock is now traded at around $273.240000. The impact to a portfolio due to this purchase was 0.37%. The holding were 84,000 shares as of 2021-09-30.

New Purchase: Nuvalent Inc (NUVL)

Avoro Capital Advisors LLC initiated holding in Nuvalent Inc. The purchase prices were between $18.25 and $38.35, with an estimated average price of $29.21. The stock is now traded at around $23.980000. The impact to a portfolio due to this purchase was 0.35%. The holding were 1,257,671 shares as of 2021-09-30.

New Purchase: Tango Therapeutics Inc (TNGX)

Avoro Capital Advisors LLC initiated holding in Tango Therapeutics Inc. The purchase prices were between $9.56 and $17.3, with an estimated average price of $13.13. The stock is now traded at around $13.510000. The impact to a portfolio due to this purchase was 0.31%. The holding were 1,550,000 shares as of 2021-09-30.

Added: Acceleron Pharma Inc (XLRN)

Avoro Capital Advisors LLC added to a holding in Acceleron Pharma Inc by 33.33%. The purchase prices were between $115.25 and $182.78, with an estimated average price of $130.74. The stock is now traded at around $173.981100. The impact to a portfolio due to this purchase was 2.7%. The holding were 4,000,000 shares as of 2021-09-30.

Added: Apellis Pharmaceuticals Inc (APLS)

Avoro Capital Advisors LLC added to a holding in Apellis Pharmaceuticals Inc by 397.40%. The purchase prices were between $31.4 and $69.84, with an estimated average price of $56.51. The stock is now traded at around $42.200000. The impact to a portfolio due to this purchase was 2.07%. The holding were 5,000,000 shares as of 2021-09-30.

Added: Amicus Therapeutics Inc (FOLD)

Avoro Capital Advisors LLC added to a holding in Amicus Therapeutics Inc by 42.00%. The purchase prices were between $8.74 and $11.84, with an estimated average price of $10.24. The stock is now traded at around $11.805000. The impact to a portfolio due to this purchase was 0.78%. The holding were 17,679,273 shares as of 2021-09-30.

Added: PMV Pharmaceuticals Inc (PMVP)

Avoro Capital Advisors LLC added to a holding in PMV Pharmaceuticals Inc by 60.27%. The purchase prices were between $26.84 and $36.58, with an estimated average price of $31.89. The stock is now traded at around $24.440000. The impact to a portfolio due to this purchase was 0.52%. The holding were 2,925,000 shares as of 2021-09-30.

Added: Avidity Biosciences Inc (RNA)

Avoro Capital Advisors LLC added to a holding in Avidity Biosciences Inc by 111.01%. The purchase prices were between $18.16 and $25.21, with an estimated average price of $21.73. The stock is now traded at around $24.840000. The impact to a portfolio due to this purchase was 0.23%. The holding were 1,150,000 shares as of 2021-09-30.

Sold Out: (CNST)

Avoro Capital Advisors LLC sold out a holding in . The sale prices were between $33.9 and $33.99, with an estimated average price of $33.95.

Sold Out: Relmada Therapeutics Inc (RLMD)

Avoro Capital Advisors LLC sold out a holding in Relmada Therapeutics Inc. The sale prices were between $21.86 and $34.77, with an estimated average price of $26.82.

Sold Out: Olema Pharmaceuticals inc (OLMA)

Avoro Capital Advisors LLC sold out a holding in Olema Pharmaceuticals inc. The sale prices were between $22.96 and $30.13, with an estimated average price of $27.02.

Sold Out: Centessa Pharmaceuticals PLC (CNTA)

Avoro Capital Advisors LLC sold out a holding in Centessa Pharmaceuticals PLC. The sale prices were between $16.7 and $23.11, with an estimated average price of $20.76.

Sold Out: BCTG Acquisition Corp (BCTG)

Avoro Capital Advisors LLC sold out a holding in BCTG Acquisition Corp. The sale prices were between $9.88 and $11.33, with an estimated average price of $10.53.

Sold Out: Adaptimmune Therapeutics PLC (ADAP)

Avoro Capital Advisors LLC sold out a holding in Adaptimmune Therapeutics PLC. The sale prices were between $3.44 and $6.37, with an estimated average price of $4.49.



Here is the complete portfolio of Avoro Capital Advisors LLC. Also check out:

1. Avoro Capital Advisors LLC's Undervalued Stocks
2. Avoro Capital Advisors LLC's Top Growth Companies, and
3. Avoro Capital Advisors LLC's High Yield stocks
4. Stocks that Avoro Capital Advisors LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus